|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 93 No. 4 (February 15), 1999:
pp. 1422-1429
Anionic Polysaccharides Inhibit Adhesion of Sickle Erythrocytes to
the Vascular Endothelium and Result in Improved Hemodynamic Behavior
G.A. Barabino,
X.D. Liu,
B.M. Ewenstein, and
D.K. Kaul
From the Department of Chemical Engineering, Northeastern University,
Boston, MA; the Department of Medicine, Albert Einstein College of
Medicine, Bronx, NY; and the Hematology Division, Brigham & Women's
Hospital, Boston, MA.
The abnormal adherence of sickle red blood cells (SS RBC) to
vascular endothelium may play an important role in vasoocclusion in
sickle cell anemia. Thrombospondin (TSP), unusually large molecular weight forms of von Willebrand factor, and laminin are known to enhance
adhesion of SS RBC. Also, these endothelial proteins bind to sulfated
glycolipids and this binding is inhibited by anionic polysaccharides.
Reversible sickling may expose normally cryptic membrane sulfatides
that could mediate this adhesive interaction. In this study, we have
investigated the effect of anionic polysaccharides, in the presence or
absence of TSP, on SS RBC adhesion to the endothelium, using cultured
human umbilical vein endothelial cells (HUVEC) (for the adhesion assay)
and the ex vivo mesocecum of the rat (for hemodynamic evaluation). The
baseline adhesion (ie, without added TSP) of SS RBC to HUVEC was most
effectively inhibited by high molecular weight dextran sulfate (HDS),
whereas low molecular weight dextran sulfate (LDS) and the
glycosaminoglycan chondroitin sulfate A (CSA) also had significant
inhibitory effects. Heparin was mildly effective whereas other
glycosaminoglycans (chondroitin sulfates B and C, heparan sulfate, and
fucoidan) were ineffective. Similarly, HDS and CSA resulted in an
improved hemodynamic behavior of SS RBC. Soluble TSP caused significant
increases in SS RBC adhesion and in the peripheral resistance. Both HDS
and CSA prevented TSP-enhanced adhesion and hemodynamic abnormalities.
Thus, anionic polysaccharides can inhibit SS RBC-endothelium
interaction in the presence or absence of soluble TSP. These agents may
interact with RBC membrane component(s) and prevent TSP-mediated
adhesion of SS RBC to the endothelium.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. M. Finnegan, G. A. Barabino, X.-d. Liu, H.-Y. Chang, A. Jonczyk, and D. K. Kaul
Small-molecule cyclic {alpha}Vbeta3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion
Am J Physiol Heart Circ Physiol,
August 1, 2007;
293(2):
H1038 - H1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Kaul, X.-d. Liu, X. Zhang, T. Mankelow, S. Parsons, F. Spring, X. An, N. Mohandas, D. Anstee, and J. A. Chasis
Peptides based on {alpha}V-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation
Am J Physiol Cell Physiol,
November 1, 2006;
291(5):
C922 - C930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Kaul, X.-d. Liu, X. Zhang, L. Ma, C. J. C. Hsia, and R. L. Nagel
Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants
Am J Physiol Heart Circ Physiol,
July 1, 2006;
291(1):
H167 - H175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Embury, N. M. Matsui, S. Ramanujam, T. N. Mayadas, C. T. Noguchi, B. A. Diwan, N. Mohandas, and A. T. W. Cheung
The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo
Blood,
November 15, 2004;
104(10):
3378 - 3385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Buchanan, M. R. DeBaun, C. T. Quinn, and M. H. Steinberg
Sickle Cell Disease
Hematology,
January 1, 2004;
2004(1):
35 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Watkins, L. M. Du, J. P. Scott, W. H. Ouwehand, and C. A. Hillery
Single-chain antibody fragments derived from a human synthetic phage-display library bind thrombospondin and inhibit sickle cell adhesion
Blood,
July 15, 2003;
102(2):
718 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Matsui, A. Varki, and S. H. Embury
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin
Blood,
November 15, 2002;
100(10):
3790 - 3796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Y. Setty, S. Kulkarni, and M. J. Stuart
Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion
Blood,
March 1, 2002;
99(5):
1564 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Y. Setty, S. Kulkarni, C. D. Dampier, and M. J. Stuart
Fetal hemoglobin in sickle cell anemia: relationship to erythrocyte adhesion markers and adhesion
Blood,
May 1, 2001;
97(9):
2568 - 2573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Manodori, G. A. Barabino, B. H. Lubin, and F. A. Kuypers
Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
Blood,
February 15, 2000;
95(4):
1293 - 1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Kaul, H. M. Tsai, X. D. Liu, M. T. Nakada, R. L. Nagel, and B. S. Coller
Monoclonal antibodies to alpha Vbeta 3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor
Blood,
January 15, 2000;
95(2):
368 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |